Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lacomis

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Acta Neuropathologica Communications|December 9, 2017
Clinical and neuropathological features of ALS/FTD with TIA1 mutationsVeronica Hirsch-Reinshagen, Cyril Pottier, Alexandra M Nicholson, et al.
Journal of the Peripheral Nervous System : JPNS|December 3, 2003
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathyAlan R Berger, Walter G Bradley, Thomas H Brannagan, et al.
Muscle & Nerve|December 19, 2020
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trialMichael D Weiss, Eric A Macklin, Courtney E McIlduff, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Signal properties and stability of a chronically implanted endovascular brain computer interfaceNikole Chetty, Kriti Kacker, Ariel K Feldman, et al.
Neuron|August 18, 2017
TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule DynamicsIan R Mackenzie, Alexandra M Nicholson, Mohona Sarkar, et al.
Science Translational Medicine|March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Acta Neuropathologica Communications|December 9, 2017
Clinical and neuropathological features of ALS/FTD with TIA1 mutationsVeronica Hirsch-Reinshagen, Cyril Pottier, Alexandra M Nicholson, et al.
Journal of the Peripheral Nervous System : JPNS|December 3, 2003
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathyAlan R Berger, Walter G Bradley, Thomas H Brannagan, et al.
Muscle & Nerve|December 19, 2020
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trialMichael D Weiss, Eric A Macklin, Courtney E McIlduff, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Signal properties and stability of a chronically implanted endovascular brain computer interfaceNikole Chetty, Kriti Kacker, Ariel K Feldman, et al.
Neuron|August 18, 2017
TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule DynamicsIan R Mackenzie, Alexandra M Nicholson, Mohona Sarkar, et al.
Science Translational Medicine|March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 13